withdrawn behavior. Ophthalmic blurred vision – Newsemia

withdrawn behavior. Ophthalmic blurred vision

PREDNISONE Tablet [A-S Medication Solutions]

September 25, 2018
0
Category:
- Pharma / Biotech
Tags: abdominal pain acneiform eruptions aggravation/masking of infections allergic dermatitis Allergic Reactions anaphylactoid or hypersensitivity reactions alopecia amenorrhea anaphylaxis and occupational performance)angioedema angioedema. Cardiovascular System bradycardia angioneurotic edema anorexia which may result in weight loss anxiety as in trauma aseptic necrosis of femoral and humeral heads atrophy and thinning of skin attention benign intracranial hypertension buffalo hump cardiac arrest cardiac arrhythmias cardiac enlargement cataracts (including posterior subcapsular cataracts)central serous chorioretinopathy circulatory collapse concentration congestive heart failure constipation contact Actavis at 1-800-272-5525 or FDA at 1-800-FDA-1088 or http://www.fda.gov/ for voluntary reporting of adverse reactions.convulsions decreased carbohydrate and glucose tolerance decreased resistance to infection (see WARNINGS: Infection)delirium dementia (characterized by deficits in memory retention depression development of cushingoid state diabetes mellitus (new onset or manifestations of latent)diarrhea dizziness dry scaly skin ecchymoses and petechiae (bruising)ECG changes caused by potassium deficiency edema EEG abnormalities elevation in serum liver enzyme levels (usually reversible upon discontinuation)emotional instability and irritability erythema establishment of secondary bacterial euphoria exophthalmos facial edema fat embolism fluid retention fungal and viral infections gastric irritation glaucoma glycosuria hallucinations headache hepatomegaly hiccups hirsutism hyperglycemia hypertension or aggravation of hypertension hyperthyroidism (see WARNINGS: Endocrine)hypertrichosis hypertrophic cardiomyopathy in premature infants hypokalemia hypokalemic alkalosis hypotension or shock-like reaction hypothyroidism immunosuppresion impaired cognition impaired wound healing incidence of severe psychiatric symptoms increase risk of fracture increased appetite and weight gain increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment increased intraocular pressure (see PRECAUTIONS: Ophthalmic)increased motor activity increased or decreased motility and number of spermatozoa increased requirements for insulin or oral hypoglycemic agents in diabetics increased sweating insomnia ischemic neuropathy Karposi’s sarcoma (see PRECAUTIONS: General Precautions)life-threatening hypotension lipids abnormal long-term memory loss loss of muscle mass lupus erythematosus-like lesions malaise mania mental speed and efficiency metabolic alkalosis mood swings moon face muscle weakness myalgias myocardial rupture following recent myocardial infarction (see WARNINGS: Cardio-Renal)nausea necrotizing angiitis negative nitrogen balance caused by protein catabolism neuritis neuropathy neutropenia (including febrile neutropenia). Metabolic negative nitrogen balance due to protein catabolism. Musculoskeletal arthralgias optic nerve damage oropharyngeal candidiasis osteopenia osteoporosis (see PRECAUTIONS: Musculoskeletal)pancreatitis papilledema. Other abnormal fat deposits paresthesia pathologic fracture of long bones peptic ulcer with possible perforation and hemorrhage perforation of the small and large intestine (particularly in patients with inflammatory bowel disease)perineal irritation personality changes postmenopausal bleeding or other menstrual irregularities potassium loss psychiatric disorders including steroid psychoses or aggravation of pre-existing psychiatric conditions pulmonary edema purpura pyrexia. To report SUSPECTED ADVERSE EVENTS rash restlessness schizophrenia secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress severe tiredness or weakness)sodium retention with resulting edema. Gastrointestinal abdominal distention steroid myopathy striae subcutaneous fat atrophy suppression of growth in pediatric patients. Fluid and Electrolyte Disturbances congestive heart failure in susceptible patients suppression of reactions to skin tests surgery or illness) (see WARNINGS: Endocrine)syncope tachycardia telangiectasis tendon rupture (particularly of the Achilles tendon)thin fragile skin thinning scalp hair thromboembolism thrombophlebitis ulcerative esophagitis urticaria. Endocrine Adrenal insufficiency-greatest potential caused by high potency glucocorticoids with long duration of action (associated symptoms include; arthralgias vasculitis. Dermatologic acne verbal memory loss vertebral compression fractures. Neurological/Psychiatric amnesia vertigo vomiting. Hematologic anemia withdrawn behavior. Ophthalmic blurred vision

Updated Date: Sep 25, 2018 EST

Read more

PREDNISONE Tablet [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Jul 20, 2018 EST

Read more

PREDNISONE Tablet [NuCare Pharmaceuticls,Inc.]

Updated Date: Jul 12, 2018 EST

Read more